Inovio Pharmaceuticals Inc - Company Profile
Powered by
All the data and insights you need on Inovio Pharmaceuticals Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Inovio Pharmaceuticals Inc Strategy Report
- Understand Inovio Pharmaceuticals Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Inovio Pharmaceuticals Inc patents, including inventor and filing insights.
Patent Trends
Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
---|---|---|---|---|
EP4055033A1 | Application | KOMBINATIONSTHERAPIE ZUR BEHANDLUNG VON HIRNKREBS | A61K2039/505; A61K2039/53; A61K2039/54; A61K2039/545; A61K2039/55538; A61K2039/80; A61K2300/00; A61K31/4188; A61K39/001142; A61K39/001153; A61K39/001157; A61K39/001195; A61K39/39; A61K39/39541; A61K39/39558; A61N2005/1098; A61N5/10; A61P35/00; C07K16/2818 | September 14, 2022 |
EP4048682A2 | Application | VERBESSERTE IMPFSTOFFE GEGEN REZIDIVIERENDE PAPILLOMATOSE DER ATEMWEGE UND VERFAHREN ZU DEREN ANWENDUNG | A61K2039/53; A61K39/12; A61P31/20; C07K14/005; C07K14/5434; C12N2710/20022; C12N2710/20034 | August 31, 2022 |
US20220265800A1 | Application | CANCER VACCINES TARGETING LEMD1 AND USES THEREOF | A61K2039/53; A61K2039/54; A61K2039/572; A61K39/001184; C07K14/47 | August 25, 2022 |
KR102436439B1 | Grant | A MINIMINALLY INVASIVE DERMAL ELECTROPORATION DEVICE | A61K2039/53; A61M2037/0007; A61M37/00; A61N1/0412; A61N1/0424; A61N1/0476; A61N1/327; C12M35/02; C12N15/87 | August 25, 2022 |
AU2017214656B2 | Grant | Cancer vaccines and methods of treatment using the same | A61K2039/53; A61K2039/54; A61K2039/552; A61K2039/55527; A61K2039/572; A61K2039/585; A61K38/20; A61K39/0011; A61K39/001157; A61K39/39; A61K9/0009; A61P35/00; C07K14/47; C12N9/1276; C12Y207/07049 | August 25, 2022 |
Top Inventors by Filings (Count by publication)
Name | Count |
---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer